plasmid 33 option 1
plasmid #33 option 2
plasmid #33 option 3
  • Load image into Gallery viewer, plasmid 33 option 1
  • Load image into Gallery viewer, plasmid #33 option 2
  • Load image into Gallery viewer, plasmid #33 option 3

Plasmid #33 – DISCONTINUED

Regular price
$240.00
Sale price
$240.00
Regular price
Sold out
Unit price
per 

Plasmid #33 enables target proteins to be labeled with C-terminal His8 and CL7. The His8 tag remains attached depending on the protease utilized. 

SKU: 20-1033

EXPRESSION
Transcription is induced with IPTG and driven by the T7 RNA polymerase. The plasmid is designed for expression in E. coli

PEPTIDE TAG
The C-terminal CL7 tag is downstream of three PreScission protease (PSC) cleavage sites, one Sortase A (SRT) cleavage site, and a His8 tag. 

CLEAVAGE SITE(S)
Plasmid #33 includes an N-terminal SUMO cleavage site, three PSC, and one SRT C-terminal cleavage sites. 

OTHER TAGS
The encoded region begins with a Trx tag. A C-terminal His8 tag is also present upstream of the CL7 tag. 

 

CLONING OPTIONS
1. HindIII/SpeI Insertion Site – Trx | SUMO | Gene of Interest | SRT | His8 | PSC | PSC | PSC | CL7

This insertion option results in 7 extra aa at the N terminus of the target following SUMO protease cleavage. 

2. KpnI/SpeI Insertion Site – Trx | SUMO | Gene of Interest | SRT | His8 | PSC | PSC | PSC | CL7

This insertion option results in 2 extra aa at the N terminus of the target following SUMO protease cleavage. 

3. Bsu36I/SpeI Insertion Site – Trx | SUMO | Gene of Interest | SRT | His8 | PSC | PSC | PSC | CL7

This insertion option maintains the Gene of Interest’s wildtype sequence, without adding any extra residues. The N-terminus of the Gene of Interest must include the following to complete the SUMO C-terminal sequence:

EXPIRATION | 6 months from receipt when stored as directed

Plasmid Sequences are available on the Plasmid Guide Page

Use of TriAltus products falls under our limited license agreement and is for non-profit research use only. For commercial use, please contact us for licensing.